These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 33183792)
1. Chromophobe renal cell carcinoma: current and controversial issues. Moch H; Ohashi R Pathology; 2021 Jan; 53(1):101-108. PubMed ID: 33183792 [TBL] [Abstract][Full Text] [Related]
2. Chromophobe renal cell carcinoma, oncocytic variant: a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors. Kuroda N; Tanaka A; Yamaguchi T; Kasahara K; Naruse K; Yamada Y; Hatanaka K; Shinohara N; Nagashima Y; Mikami S; Oya M; Hamashima T; Michal M; Hes O Med Mol Morphol; 2013 Mar; 46(1):49-55. PubMed ID: 23338778 [TBL] [Abstract][Full Text] [Related]
3. WHO 2022 landscape of papillary and chromophobe renal cell carcinoma. Lobo J; Ohashi R; Amin MB; Berney DM; Compérat EM; Cree IA; Gill AJ; Hartmann A; Menon S; Netto GJ; Raspollini MR; Rubin MA; Tan PH; Tickoo SK; Tsuzuki T; Turajlic S; Zhou M; Srigley JR; Moch H Histopathology; 2022 Oct; 81(4):426-438. PubMed ID: 35596618 [TBL] [Abstract][Full Text] [Related]
4. [Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study]. Zhang W; Wang K; Yu W; Liu Y; Chu J; Jiang Y; Li Y Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):767-71. PubMed ID: 26888385 [TBL] [Abstract][Full Text] [Related]
5. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling. Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590 [TBL] [Abstract][Full Text] [Related]
6. Cathepsin K (Clone EPR19992) Demonstrates Uniformly Positive Immunoreactivity in Renal Oncocytoma, Chromophobe Renal Cell Carcinoma, and Distal Tubules. Iakymenko OA; Delma KS; Jorda M; Kryvenko ON Int J Surg Pathol; 2021 Sep; 29(6):600-605. PubMed ID: 33764165 [No Abstract] [Full Text] [Related]
7. Diagnostic approach to eosinophilic renal neoplasms. Kryvenko ON; Jorda M; Argani P; Epstein JI Arch Pathol Lab Med; 2014 Nov; 138(11):1531-41. PubMed ID: 25357116 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical application of S100A1 in renal oncocytoma, oncocytic papillary renal cell carcinoma, and two variants of chromophobe renal cell carcinoma. Kuroda N; Kanomata N; Yamaguchi T; Imamura Y; Ohe C; Sakaida N; Hes O; Michal M; Shuin T; Lee GH Med Mol Morphol; 2011 Jun; 44(2):111-5. PubMed ID: 21717314 [TBL] [Abstract][Full Text] [Related]
10. Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal cell tumors. Tickoo SK; Amin MB; Linden MD; Lee MW; Zarbo RJ Am J Surg Pathol; 1997 Aug; 21(8):922-30. PubMed ID: 9255255 [TBL] [Abstract][Full Text] [Related]
11. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases. Pan CC; Chen PC; Ho DM Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648 [TBL] [Abstract][Full Text] [Related]
12. Immunostaining characteristics of irisin in benign and malignant renal cancers. Kuloğlu T; Artaş G; Yardim M; Sahin I; Aydin Y; Beyoğlu N; Özercan IH; Yalcin MH; Ugur K; Aydin S Biotech Histochem; 2019 Aug; 94(6):435-441. PubMed ID: 30896263 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Adley BP; Papavero V; Sugimura J; Teh BT; Yang XJ Anal Quant Cytol Histol; 2006 Aug; 28(4):228-36. PubMed ID: 16927643 [TBL] [Abstract][Full Text] [Related]
14. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture. Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical identification of intracytoplasmic lumens by cytokeratin typing may differentiate renal oncocytomas from chromophobe renal cell carcinomas. Kuroda N; Toi M; Yamamoto M; Miyazaki E; Hayashi Y; Hiroi M; Shuin T; Enzan H Histol Histopathol; 2004 Jan; 19(1):23-8. PubMed ID: 14702167 [TBL] [Abstract][Full Text] [Related]
16. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma. Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433 [TBL] [Abstract][Full Text] [Related]
17. Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms. Skala SL; Wang X; Zhang Y; Mannan R; Wang L; Narayanan SP; Vats P; Su F; Chen J; Cao X; Siddiqui J; Argani P; Cieślik MP; Giordano TJ; Chinnaiyan AM; Dhanasekaran SM; Mehra R Eur Urol; 2020 Jul; 78(1):63-74. PubMed ID: 32299640 [TBL] [Abstract][Full Text] [Related]
18. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570 [TBL] [Abstract][Full Text] [Related]
19. Renal Oncocytoma With Both Lymphovascular Invasion and Prominent Intracytoplasmic Vacuole-Like Spaces: A Case Report and Review of the Literature. Luo X; Preciado C; Nayak A; Schwartz LE; Guzzo TJ; Williamson SR; Palmer MB; Lal P Int J Surg Pathol; 2022 May; 30(3):300-306. PubMed ID: 34488464 [TBL] [Abstract][Full Text] [Related]
20. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma. Wang HY; Mills SE Am J Surg Pathol; 2005 May; 29(5):640-6. PubMed ID: 15832088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]